Cesca: Cesca Therapeutics And ThermoGenesis Announce Major Global Distribution Agreement For The Company's X-Series® Products
The Company will receive a $2 million upfront distribution fee, and future market support for granting the exclusive rights.
Read full article »
Cesca develops and commercializes cell-based therapeutics for the treatment of immuno-oncology, vascular, cardiology and orthopedic diseases.
Read more